U.S. market Closed. Opens in 12 hours 8 minutes

SRDX | Surmodics, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for SRDX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is strong.

Valuation (14%)

Company Industry
P/E Ratio (TTM) -398.66 40.66
PEG Ratio (TTM) -47.84 5.42
P/S Ratio (TTM) 4.65 6.33
P/B Ratio (TTM) 4.72 5.87
P/FCF Ratio (TTM) -95.86 37.81
Price to 5YR AVG Earnings Ratio -177.03 59.41
Price to 5YR AVG FCF Ratio 362.66 36.98

Profitability (0%)

Company Industry
ROA (TTM) -0.79% 4.66%
ROE (TTM) -1.16% 25.49%
Net Profit Margin (TTM) -1.16% 7.22%
ROIC 5YR AVG -0.96% 6.54%

Growth (28%)

4QTR AVG 3YR AVG 5YR AVG
EPS -783.51% 152.05% -36.35%
Revenue -9.48% 9.55% 11.28%
Net Income -786.87% 154.14% -37.38%
Cash Flow -210.40% 2.58% -8.63%

Health (68%)

Company Industry
Current Ratio (TTM) 3.98 2.64
Quick Ratio (TTM) 3.22 1.97
D/E Ratio (TTM) 0.26 0.55
Interest Coverage (TTM) -2.11 2.38
Piotroski F-Score 5 6
Altman Z-Score 7.29 7.18
LTL to 5YR AVG FCF 18.99 3.69
Shares Outstanding Growth 5YR AVG 1.30% 1.65%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙